Watch out, Gilead and Novartis: there's a new CAR-T in town ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner. The company has wrapped up all ...
BASEL, SWITZERLAND, November 11, 2024 /EINPresswire / -- On November 10th, the American Swiss Foundation's 34th Annual Young Leaders conference officially kicked off in Basel, Switzerland, sponsored ...
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
In May 2024, Google DeepMind released AlphaFold 3, a game changing protein folding model that predicts with 50% better ...
4h
Analyst Thomas Smith of Leerink Partners reiterated a Buy rating on MoonLake Immunotherapeutics (MLTX – Research Report), retaining the ...
Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...
Thailand Pharmaceutical Industry, according to Fitch Solutions, the pharmaceutical market in Southeast Asia has a market size ...
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
Medpage Today on MSN14h
ObesityWeek Roundup: Patients More Likely to Ration Obesity DrugsAdults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...
Switzerland is generally considered an attractive place to live and work in, but what specific benefits are foreigners ...
Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter ...
Optic, a digital biology company redefining drug discovery with AI, announced a collaboration with Vindur Tx, an early-stage oncology therapeutics venture. This collaboration will leverage Optic's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback